BioCentury
ARTICLE | Company News

Nabi renal, infectious, neurology news

March 19, 2007 7:00 AM UTC

The reorganization follows a strategic alternatives process that began last year (see BioCentury, Oct. 2, 2006). NABI hopes to complete the process by year end. At Dec. 31, 2006, the company had $86.2...